Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population

被引：0
|
作者：
Dhakchinamoorthi Krishna Kumar
Deepak Gopal Shewade
Marie-Anne Loriot
Philippe Beaune
Jayaraman Balachander
B. V. Sai Chandran
Chandrasekaran Adithan
机构：
[1] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Pharmacology
[2] INSERM UMRS 775,University Paris Sorbonne Cité
[3] Assistance Publique des Hôpitaux de Paris,Department of Biochemistry, Georges Pompidou European Hospital
[4] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Cardiology
[5] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Cardiothoracic and Vascular Surgery
来源：
European Journal of Clinical Pharmacology | 2014年 / 70卷
关键词：
Warfarin; Genotype; Polymorphisms; Pharmacogenetic algorithm;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：47 / 56
页数：9
相关论文
共 50 条
  • [31] Effect of CYP2C9 and VKORC1 genetic variations on warfarin dose requirements in Indian patients
    Natarajan, Sripriya
    Ponde, Chandrashekhar K.
    Rajani, Rajesh M.
    Jijina, Farah
    Gursahani, Roopkumar
    Dhairyawan, Pradnya P.
    Ashavaid, Tester F.
    PHARMACOLOGICAL REPORTS, 2013, 65 (05) : 1375 - 1382
  • [32] A network meta-analysis of CYP2C9, CYP2C9 with VKORC1 and CYP2C9 with VKORC1 and CYP4F2 genotype-based warfarin dosing strategies compared to traditional
    Sridharan, Kannan
    Sivaramakrishnan, Gowri
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (03) : 640 - 648
  • [33] Evaluation of a warfarin dosing algorithm including CYP2C9, VKORC1, and CYP4F2 polymorphisms and non-genetic determinants for the Iranian population
    Mahvash Farajzadeh-Dehkordi
    Fatemeh Samiee-Rad
    Seyed Saeed Farzam
    Amir Javadi
    Sara Cheraghi
    Dariush Hamedi-Asl
    Babak Rahmani
    Pharmacological Reports, 2023, 75 : 695 - 704
  • [34] PHARMACOGENOMIC VARIANTS OF CYP2C9, CYP4F2 AND VKORC1 AND ITS RELATION TO WARFARIN RESPONSE IN NATIVE OMANI PATIENTS
    Pathare, A.
    AlZadjali, S.
    Misquith, R.
    Gravell, D.
    Al Falahi, K.
    Al-Haddabi, H.
    Krishnamoorthy, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 668 - 668
  • [35] Effect of CYP2C9 and VKORC1 genetic polymorphism on Warfarin dose requirement
    Ashavaid, T. F.
    Ponde, C. K.
    Raghavan, R.
    Kapadia, F. N.
    Shah, S. A.
    Natarajan, S.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 507 - 508
  • [36] THE IMPACT OF CYP2C9 AND VKORC1 VARIANTS ON STABLE WARFARIN DOSE IN THE PEDIATRIC POPULATION
    Vear, Susan
    Ayers, Dan
    Stein, C. Michael
    Ho, Richard
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S34 - S35
  • [37] The effect of CYP2C9 and VKORC1 genetic polymorphisms on warfarin dose requirements in a pediatric population
    Taskin, Birce Dilge
    Kula, Serdar
    Ergun, Mehmet Ali
    Altun, Demet
    Olgunturk, Rana
    Tunaoglu, Fatma Sedef
    Oguz, Ayse Deniz
    Gursel, Turkiz
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (10): : 791 - 796
  • [38] RESPONSIVENESS OF VERY LOW-DOSE WARFARIN ASSOCIATED WITH GENETIC VARIANTS OF VKORC1, CYP2C9, CYP4F2 AND CYP2C19 IN INDONESIAN PATIENTS.
    Rusdiana, T.
    Araki, T.
    Nakamura, T.
    Subarnas, A.
    Yamamoto, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S62 - S63
  • [39] A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
    Takeuchi, Fumihiko
    McGinnis, Ralph
    Bourgeois, Stephane
    Barnes, Chris
    Eriksson, Niclas
    Soranzo, Nicole
    Whittaker, Pamela
    Ranganath, Venkatesh
    Kumanduri, Vasudev
    McLaren, William
    Holm, Lennart
    Lindh, Jonatan
    Rane, Anders
    Wadelius, Mia
    Deloukas, Panos
    PLOS GENETICS, 2009, 5 (03):
  • [40] Study of VKORC1, CYP2C9, and CYP4F2 polymorphisms and their association with warfarin dose requirements in Egyptian patients.
    Shahin, Mohamed H.
    Khalifa, Sherief I.
    Sallam, Tarif H.
    Hammad, Lamiaa N.
    El Shafey, Mostafa
    Ali, Shawky S.
    Mohamed, Mohamed-Eslam F.
    Langaee, Taimour
    Johnson, Julie A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1065 - 1065
12345